Adverse Reactions to Oral Retinoids: An Update

Drug Safety

Volumn 9, Issue 4, 1993, Pages 280-290

  Mills, Caroline M ^a   Marks, Ronald ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; ETRETINATE; ISOTRETINOIN; RETINOID; RETINOL DERIVATIVE;

ACNE; ALOPECIA; ARTHRALGIA; BLOOD TOXICITY; BRAIN PSEUDOTUMOR; CENTRAL NERVOUS SYSTEM DISEASE; CHEILITIS; CHOLESTASIS; DOSE RESPONSE; ENTERITIS; ERYTHEMA; EYE DISEASE; EYE INFLAMMATION; FEMALE; GASTROINTESTINAL DISEASE; HEPATITIS; HUMAN; HYPEROSTOSIS; KERATITIS; LIPID METABOLISM; LIVER TOXICITY; MALE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NIGHT BLINDNESS; ORAL DRUG ADMINISTRATION; PHOTOSENSITIVITY; PREGNANCY; PRURITUS; PSORIASIS; REVIEW; TERATOGENICITY; VASCULITIS; WEGENER GRANULOMATOSIS; XEROSIS;

ADMINISTRATION, ORAL; ANIMAL; FEMALE; HUMAN; RETINOIDS;

EID: 0027441207     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/00002018-199309040-00006     Document Type: Review

References (72)

1. Photoaggravated reaction to isotretinoin
2. Visual toxicity of acitretin
3. A study of etretinate alopecia
4. Blepharoconjunctivitis: a side effect of 13-cis-retinoic acid therapy for dermatologic disease
5. Acute achilles tendonitis following oral isotretinoin therapy for acne vulgaris
6. Longterm effects of etretinate on the liver in psoriasis
7. Etretinate photosensitivity
8. Epidemiology of isotretinoin exposure during pregnancy
9. Acne fulminans with arthritis in identical twins treated with isotretinoin
10. Palmoplantar eruption associated with etretinate therapy
11. Adverse effects of retinoids
12. Electromyographic abnormalities in patients undergoing long-term therapy with etretinate
13. Eruptive xanthoma associated with isotretinoin
14. Photosensitivity studies and isotretinoin therapy
15. Vasculitis and retinoids
16. Retinoids, cancer, and the skin
17. Acne associated spondylarthropathy: radiographic features
18. Etretinate therapy
19. Esophageal ulceration associated with cis-retinoic acid therapy in patients with Barrett’ s esophagus
20. Retinoid associated phototoxicity and photosensitivity
21. Leukopaenia and neutropaenia associated with isotretinoin therapy
22. Cholestatic jaundice, an unusual side effect of etretinate
23. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis
24. Ocular side effects of the retinoids
25. A review of the literature on benign intracranial hypertension associated with medication
26. Sexual dysfunction in a patient treated with etretinate
27. Peripheral neuropathy during etretinate therapy for psoriasis
28. Excessive granulation tissue during etretinate therapy
29. Etretinate-induced skeletal damage
30. Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin
31. Hepatocanalicular injury associated with vitamin A derivative etretinate. An idiosyncratic hypersensitivity reaction
32. Effects of retinoids in bone
33. Skeletal effects of acitretin used for treatment of psoriasis
34. The molecular basis of retinoic acid induced night blindness
35. Ocular problems in contact lens wearers and non-contact lens wearers on isotretinoin — practical guidelines
36. Retinoids and contraception
37. Lipid metabolism and retinoid therapy
38. Isotreinoin-associated proctosigmoiditis
39. Fatal toxic epidermal necrolysis associated with etretinate
40. Premature epiphyseal closure in a child receiving oral cis-retinoic acid
41. Oral retinoids: what should the prescriber know about their tertatogenic hazards among women of child bearing potential?
42. A double-blind, placebo controlled trial of acetretin for the treatment of psoriasis
43. Laboratory investigation in patients with generalised pustular psoriasis under oral retinoid treatment. A multicentre study of computerised data
44. The importance of precorneal tear film for the quality of optical imaging
45. Isotretinoin in lacrimal gland fluid and tears
46. Liver toxicity in retinoid therapy
47. Ocular side effects of oral treatment with retinoids
48. Acute depression from isotretinoin
49. Oral isotretinoin and inflammatory bowel disease
50. Mucocutaneous and systemic toxicity of retinoids: monitoring and management
51. Isotretinoin treatment of acne and related disorders: an update
52. Isotretinoin therapy for acne: results of a multicentre dose response study
53. The recognition and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society
54. Teratogenicity of the retinoids
55. Skeletal hyperostosis in patients recieving chronic, very low dose isotretinoin
56. Fatty liver following isotretinoin therapy
57. Spinal cord compession after long-term etretinate
58. Identification and spacial distribution of retinoids in the chick limb bud
59. Spermatological investigations in patients treated with etretinate and isotretinoin
60. Acetretin and blood lipids
61. A sequential comparison of etretinate (Tigason) and isotretinoin (Roaccutane) with special regard to their effects on serum lipoproteins
62. Benign intracranial hypertension during etreinate therapy for mycosis fungoides
63. Serum lipid elevation during isotretinoin therapy for acne in the West of Scotland
64. Rod and cone malfunction as a manifestation of isotretinoin therapy — a case report
65. Abnormal retinal function associated with long-term etretinate?
66. Chronic active hepatitis associated with etretinate therapy
67. Bone changes associated with oral retinoid therapy
68. Pharmacokinetics of acitretin in humans
69. Multiple pyogenic granulomata occurring during etretinate therapy
70. General clinical toxicology of oral retinoids
71. Cutaneous vasculitis and psoriasis
72. Ossification de la membrane inter-osseuse antibrachiale sous etretinate